Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.569 Q2 | 81 | 55 | 756 | 2389 | 1526 | 695 | 1.91 | 43.44 | |
52 | Advanced Therapeutics | journal | 1.063 Q1 | 39 | 159 | 324 | 12890 | 1482 | 319 | 4.31 | 81.07 | |
53 | Drug Resistance Updates | journal | 4.665 Q1 | 132 | 74 | 76 | 6493 | 1477 | 75 | 17.53 | 87.74 | |
54 | Chinese Traditional and Herbal Drugs | journal | 0.169 Q4 | 24 | 813 | 2421 | 32473 | 1451 | 2421 | 0.60 | 39.94 | |
55 | Expert Review of Clinical Pharmacology | journal | 0.990 Q1 | 60 | 112 | 384 | 8775 | 1441 | 357 | 3.53 | 78.35 | |
56 | European Journal of Clinical Pharmacology | journal | 0.727 Q2 | 123 | 163 | 626 | 6493 | 1431 | 530 | 2.25 | 39.83 | |
57 | Journal of Clinical Pharmacology | journal | 0.717 Q2 | 130 | 195 | 567 | 7254 | 1411 | 510 | 2.46 | 37.20 | |
58 | Current Treatment Options in Oncology | journal | 1.326 Q1 | 66 | 115 | 332 | 8845 | 1403 | 327 | 3.91 | 76.91 | |
59 | Cancer Chemotherapy and Pharmacology | journal | 0.869 Q2 | 122 | 109 | 496 | 3935 | 1395 | 488 | 2.73 | 36.10 | |
60 | Expert Opinion on Drug Safety | journal | 0.905 Q1 | 90 | 165 | 441 | 8337 | 1384 | 401 | 3.03 | 50.53 | |
61 | Pharmacoepidemiology and Drug Safety | journal | 1.106 Q1 | 109 | 149 | 547 | 5012 | 1367 | 506 | 2.12 | 33.64 | |
62 | Breast Cancer | journal | 1.054 Q1 | 66 | 105 | 381 | 3752 | 1338 | 373 | 3.29 | 35.73 | |
63 | Drug Safety | journal | 1.204 Q1 | 140 | 108 | 359 | 4530 | 1291 | 313 | 3.33 | 41.94 | |
64 | Annals of Pharmacotherapy | journal | 0.779 Q2 | 122 | 238 | 521 | 7071 | 1287 | 409 | 2.25 | 29.71 | |
65 | International Journal of Neuropsychopharmacology | journal | 1.525 Q1 | 125 | 79 | 261 | 4188 | 1265 | 254 | 4.59 | 53.01 | |
66 | Journal of Oncology Pharmacy Practice | journal | 0.408 Q3 | 44 | 419 | 909 | 10302 | 1193 | 841 | 1.18 | 24.59 | |
67 | International Journal of Clinical Pharmacy | journal | 0.577 Q2 | 71 | 163 | 513 | 6171 | 1192 | 464 | 2.30 | 37.86 | |
68 | Expert Review of Neurotherapeutics | journal | 0.957 Q1 | 98 | 108 | 322 | 11035 | 1154 | 289 | 3.25 | 102.18 | |
69 | Cardiovascular Drugs and Therapy | journal | 0.973 Q1 | 79 | 227 | 345 | 10672 | 1131 | 312 | 3.13 | 47.01 | |
70 | CPT: Pharmacometrics and Systems Pharmacology | journal | 0.975 Q1 | 55 | 181 | 347 | 6421 | 1102 | 320 | 3.07 | 35.48 | |
71 | European Heart Journal - Cardiovascular Pharmacotherapy | journal | 1.507 Q1 | 40 | 94 | 329 | 2657 | 1095 | 203 | 3.62 | 28.27 | |
72 | BioDrugs | journal | 1.796 Q1 | 79 | 62 | 166 | 5182 | 1068 | 161 | 5.59 | 83.58 | |
73 | Chinese Journal of Integrative Medicine | journal | 0.502 Q3 | 44 | 155 | 414 | 7284 | 1062 | 404 | 2.22 | 46.99 | |
74 | Advances in Clinical and Experimental Medicine | journal | 0.535 Q3 | 43 | 154 | 488 | 6539 | 1045 | 483 | 2.15 | 42.46 | |
75 | Anti-Cancer Drugs | journal | 0.476 Q3 | 102 | 143 | 526 | 4507 | 1045 | 525 | 1.89 | 31.52 | |
76 | Expert Review of Anticancer Therapy | journal | 0.827 Q2 | 85 | 123 | 370 | 8783 | 1034 | 330 | 2.78 | 71.41 | |
77 | Pharmacotherapy | journal | 0.943 Q1 | 126 | 123 | 305 | 5918 | 1029 | 286 | 3.02 | 48.11 | |
78 | Therapeutics and Clinical Risk Management | journal | 0.752 Q2 | 70 | 90 | 357 | 4189 | 986 | 352 | 2.35 | 46.54 | |
79 | Journal of Applied Pharmaceutical Science | journal | 0.258 Q3 | 56 | 276 | 696 | 14302 | 945 | 695 | 1.23 | 51.82 | |
80 | HIV Medicine | journal | 1.052 Q1 | 86 | 151 | 348 | 5203 | 911 | 321 | 2.64 | 34.46 | |
81 | Iranian Journal of Pharmaceutical Research | journal | 0.385 Q3 | 58 | 62 | 435 | 2434 | 902 | 432 | 1.87 | 39.26 | |
82 | Cannabis and Cannabinoid Research | journal | 0.932 Q1 | 42 | 173 | 194 | 8890 | 873 | 183 | 4.16 | 51.39 | |
83 | Clinical Drug Investigation | journal | 0.680 Q2 | 67 | 96 | 332 | 2966 | 860 | 305 | 2.63 | 30.90 | |
84 | Therapeutic Drug Monitoring | journal | 0.591 Q2 | 102 | 116 | 328 | 4136 | 846 | 295 | 2.68 | 35.66 | |
85 | Cancer Drug Resistance | journal | 1.035 Q1 | 24 | 47 | 210 | 5023 | 844 | 205 | 4.27 | 106.87 | |
86 | Targeted Oncology | journal | 1.421 Q1 | 59 | 80 | 206 | 3070 | 815 | 200 | 3.84 | 38.38 | |
87 | Therapeutic Innovation and Regulatory Science | journal | 0.637 Q2 | 51 | 129 | 419 | 3922 | 814 | 374 | 2.24 | 30.40 | |
88 | Drugs and Aging | journal | 0.894 Q1 | 109 | 86 | 254 | 5801 | 811 | 246 | 3.24 | 67.45 | |
89 | International Journal of STD and AIDS | journal | 0.540 Q3 | 78 | 156 | 556 | 4040 | 810 | 535 | 1.35 | 25.90 | |
90 | Therapeutic Advances in Respiratory Disease | journal | 1.179 Q1 | 50 | 78 | 206 | 3651 | 791 | 194 | 3.55 | 46.81 | |
91 | World Journal of Men?s Health | journal | 0.824 Q2 | 29 | 72 | 199 | 4234 | 786 | 188 | 3.46 | 58.81 | |
92 | BMC pharmacology & toxicology | journal | 0.710 Q2 | 43 | 77 | 253 | 2925 | 763 | 253 | 2.92 | 37.99 | |
93 | Clinical Pharmacology in Drug Development | journal | 0.626 Q2 | 35 | 140 | 398 | 3021 | 753 | 385 | 1.86 | 21.58 | |
94 | Expert Review of Pharmacoeconomics and Outcomes Research | journal | 0.671 Q2 | 61 | 118 | 329 | 5270 | 745 | 315 | 1.79 | 44.66 | |
95 | Experimental and Clinical Psychopharmacology | journal | 0.827 Q2 | 101 | 63 | 309 | 3335 | 740 | 308 | 2.43 | 52.94 | |
96 | Fundamental and Clinical Pharmacology | journal | 0.586 Q2 | 85 | 110 | 288 | 7063 | 732 | 272 | 2.48 | 64.21 | |
97 | Tropical Journal of Pharmaceutical Research | journal | 0.183 Q4 | 49 | 327 | 1129 | 6629 | 698 | 1129 | 0.56 | 20.27 | |
98 | Journal of Clinical Psychopharmacology | journal | 0.728 Q2 | 130 | 143 | 454 | 3596 | 682 | 227 | 1.60 | 25.15 | |
99 | Frontiers in Medical Technology | journal | 0.602 Q2 | 15 | 67 | 210 | 2797 | 661 | 193 | 2.60 | 41.75 | |
100 | Clinical Psychopharmacology and Neuroscience | journal | 0.802 Q2 | 42 | 66 | 242 | 3193 | 652 | 237 | 2.33 | 48.38 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®